Lazard Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $36K | Sell |
|
|||||
|
2024
Q4 | $989K | Buy |
|
|||||
|
2024
Q3 | $1.77M | Buy |
|
|||||
|
2024
Q2 | $920K | Buy |
|
|||||
|
2024
Q1 | $449K | Buy |
|
|||||
|
2023
Q4 | $231K | Buy |
|
|||||
|
2023
Q3 | $191K | Buy |
|
|||||
|
2023
Q2 | $107K | Buy |
|
|||||
|
2023
Q1 | $63K | Buy |
|
|||||
|
2022
Q4 | $17K | Hold |
|
|||||
|
2022
Q3 | $23K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $54K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $14K | Buy |
|